Chronic obstructive pulmonary disease and neutrophil infiltration: Role of cigarette smoke and cyclooxygenase products

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 298, Issue 2, 2010, Pages

  Profita, Mirella ^a   Sala, Angelo ^b   Bonanno, Anna ^a   Riccobono, Loredana ^a   Ferraro, Maria ^a   La Grutta, Stefania ^c   Albano, Giusy Daniela ^a   Montalbano, Angela Marina ^a   Gjomarkaj, Mark ^a  

^a CNR   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Agenzia Regionale per la Protezione dell'Ambiente (ARPA Sicilia)   (Italy)

Author keywords

Alveolar macrophages; Cigarette smoke extract; Cyclooxygenase 2; Neutrophils

Indexed keywords

CIGARETTE SMOKE; CYCLOOXYGENASE 2; E PROSTANOID 4; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTANOID; UNCLASSIFIED DRUG;

ADULT; AGED; AIRWAY; ARTICLE; BLOOD SAMPLING; BRONCHUS MUCOSA; CELL ADHESION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EOSINOPHIL; EPITHELIUM CELL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; SPUTUM; SPUTUM ANALYSIS; SUPERNATANT;

AGED; CELL ADHESION; DINOPROSTONE; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; NEUTROPHILS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN ISOFORMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, PROSTAGLANDIN E; SMOKE; SMOKING; SPUTUM;

EID: 74949087408     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90593.2008     Document Type: Article

References (44)

1. 2 and selective EP agonists on chemotaxis of human neutrophils. Br J Pharmacol 116: 2903-2908, 1995.
2. Bloemen PG, van den Tweel MC, Henricks PA, Engels F, Kester MH, van de Loo PG, Blomjous FJ, Nijkamp FP. Increased cAMP levels in stimulated neutrophils inhibit their adhesion to human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 272: L580-L587, 1997.
3. Capra V, Thompson MD, Sala A, Cole DE, Folco G, Rovati GE. Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. Med Res Rev 27: 469-527, 2007.
4. 2 and matrix metalloproteinase-2 correlate with the severity of airflow limitation in stable COPD. Respirology 13: 1014-1021, 2008.
5. Church DF, Pryor WA. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64: 111-126, 1985.
6. 4 are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res (Phila Pa) 2: 322-329, 2009.
7. Grootendorst DC, Gauw SA, Verhoosel RM, Sterk PJ, Hospers JJ, Bredenbroker D, Bethke TD, Hiemstra PS, Rabe KF. Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD. Thorax 62: 1081-1087, 2007.
8. Hargreave FE, Popov T, Kidney J, Dolovich J. Sputum measurements to assess airway inflammation in asthma. Allergy 48: 81-83; discussion 84-86, 1993.
9. Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 93: 391-396, 1994.
10. Koethe SM, Kuhnmuench JR, Becker CG. Neutrophil priming by cigarette smoke condensate and a tobacco anti-idiotypic antibody. Am J Pathol 157: 1735-1743, 2000.
11. +). Thorax 58: 23-29, 2003.
12. Luppi F, Aarbiou J, van Wetering S, Rahman I, de Boer WI, Rabe KF, Hiemstra PS. Effects of cigarette smoke condensate on proliferation and wound closure of bronchial epithelial cells in vitro: role of glutathione. Respir Res 6: 140, 2005.
13. 2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol 287: L981-L991, 2004.
14. Martin-Garcia C, Hinojosa M, Berges P, Camacho E, Garcia-Rodriguez R, Alfaya T, Iscar A. Safety of a cyclooxygenase-2 inhibitor in patients with aspirin-sensitive asthma. Chest 121: 1812-1817, 2002.
15. Merendino AM, Bucchieri F, Gagliardo R, Daryadel A, Pompeo F, Chiappara G, Santagata R, Bellia V, David S, Farina F, Davies DE, Simon HU, Vignola AM. CD40 ligation protects bronchial epithelium against oxidant-induced caspase-independent cell death. Am J Respir Cell Mol Biol 35: 155-164, 2006.
16. Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med 155: 1770-1776, 1997.
17. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162: 1175-1177, 2000.
18. Montuschi P, Kharitonov SA, Ciabattoni G, Barnes PJ. Exhaled leukotrienes and prostaglandins in COPD. Thorax 58: 585-588, 2003.
19. Montuschi P, Macagno F, Parente P, Valente S, Lauriola L, Ciappi G, Kharitonov SA, Barnes PJ, Ciabattoni G. Effects of cyclo-oxygenase inhibition on exhaled eicosanoids in patients with COPD. Thorax 60: 827-833, 2005
20. Mroz RM, Chyczewska E, Korniluk M, Stasiak-Barmuta A, Ossolinska M. Comparison of cellular composition of induced sputum, bronchial washings and bronchoalveolar lavage fluid in sarcoidosis, hypersensitivity pneumonitis and COPD. Pneumonol Alergol Pol 70: 468-477, 2002.
21. Mroz RM, Holownia A, Chyczewska E, Drost EM, Braszko JJ, Noparlik J, Donaldson K, Macnee W. Cytoplasm-nuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol 58, Suppl 5: 437-444, 2007.
22. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79: 1193-1226, 1999.
23. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-1276, 2001.
24. Powell WS. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 20: 947-957, 1980.
25. 2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia. J Allergy Clin Immunol 112: 709-716, 2003.
26. 4 production and neutrophil chemotaxis in chronic bronchitis. Am J Physiol Cell Physiol 279: C1249-C1258, 2000.
27. Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative Stress Study Group. Am J Respir Crit Care Med 156: 341-357, 1997.
28. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 55: 12-18, 2000.
29. 4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med 153: 572-575, 1996.
30. Steuerwald N, Cohen J, Herrera RJ, Brenner CA. Quantification of mRNA in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR. Mol Hum Reprod 6: 448-453, 2000.
31. Stevenson DD, Simon RA. Lack of cross-reactivity between rofecoxib and aspirin in aspirin-sensitive patients with asthma. J Allergy Clin Immunol 108: 47-51, 2001.
32. Stone PC, Fisher AC, Rainger GE, Nash GB. Neutrophil capture by selectins on endothelial cells exposed to cigarette smoke. Biochem Biophys Res Commun 295: 1150-1155, 2002.
33. Su Y, Han W, Giraldo C, De Li Y, Block ER. Effect of cigarette smoke extract on nitric oxide synthase in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 19: 819-825, 1998.
34. 2 receptor in mouse peritoneal neutrophils. J Immunol 175: 2606-2612, 2005.
35. Szczeklik A, Sanak M. The broken balance in aspirin hypersensitivity. Eur J Pharmacol 533: 145-155, 2006.
36. Taha R, Olivenstein R, Utsumi T, Ernst P, Barnes PJ, Rodger IW, Giaid A. Prostaglandin H synthase 2 expression in airway cells from patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161: 636-640, 2000.
37. Tetley TD. Macrophages and the pathogenesis of COPD. Chest 121: 156S-159S, 2002.
38. Tsoumakidou M, Tzanakis N, Siafakas NM. Induced sputum in the investigation of airway inflammation of COPD. Respir Med 97: 863-871, 2003.
39. Vassallo R, Kroening PR, Parambil J, Kita H. Nicotine and oxidative cigarette smoke constituents induce immune-modulatory and pro-inflammatory dendritic cell responses. Mol Immunol 45: 3321-3329, 2008.
40. Wenzel SE. Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 17: 3S-12S, 1997.
41. Williams TJ, Jose PJ. Neutrophils in chronic obstructive pulmonary disease. Novartis Found Symp 234: 136-141; discussion 141-138, 2001.
42. 2. Cell Signal 9: 531-537, 1997.
43. 2 receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalational challenge. J Allergy Clin Immunol 114: 1309-1316, 2004.
44. 2 inhibits monocyte function by interfering with CCR5 and Mac-1. FASEB J 14: 661-668, 2000.